top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

Quanterix Names Illumina Commercial Chief Everett Cunningham as New CEO

bancheta6
Jan 14
1 min read

Billerica, MA, January 8, 2026 (Business Wire) -- Quanterix Corporation appointed Everett Cunningham as President and Chief Executive Officer, effective January 19, 2026, as part of a planned leadership transition. Cunningham joins from Illumina, where he served as Chief Commercial Officer, following earlier commercial leadership roles at Exact Sciences, Quest Diagnostics, GE Healthcare, and Pfizer. The company said it expects to exceed its full-year 2025 revenue and cash guidance, positioning Quanterix for its next phase of growth under Cunningham’s leadership.

Read full article here.

Recent Posts

Inquis Medical Raises $75M Series C to Expand AVENTUS Thrombectomy Adoption

Menlo Park, CA, January 12, 2026 (Business Wire) -- Inquis Medical closed a $75 million Series C financing from an undisclosed strategic investor to accelerate nationwide commercial expansion of its

Haemonetics Buys Ireland-based Vivasure to Expand Vascular Closure Portfolio

Boston, MA, January 9, 2026 (PRNewswire) -- Haemonetics Corporation announced the acquisition of Vivasure Medical Limited, a Galway-based medtech company developing next-generation percutaneous vess

Henry Schein appoints Frederick M. Lowery as CEO, Succeeding Longtime Leader Stanley Bergman

Melville, NY, January 12, 2026 (Business Wire) -- Henry Schein, Inc. announced the appointment of Frederick M. Lowery as Chief Executive Officer, effective March 2, 2026, at which point he will also

Comments

Life Science Headlines

Inquis Medical Raises $75M Series C to Expand AVENTUS Thrombectomy Adoption

Quanterix Names Illumina Commercial Chief Everett Cunningham as New CEO

Haemonetics Buys Ireland-based Vivasure to Expand Vascular Closure Portfolio

Henry Schein appoints Frederick M. Lowery as CEO, Succeeding Longtime Leader Stanley Bergman

Lilly Strikes $1.2B deal to Acquire Ventyx and Bolster Oral Anti-inflammatory Drug Pipeline

Syremis Launches with $165M Series A to Advance Schizophrenia and Depression Pipeline

PureTech Appoints Robert Lyne as Chief Executive Officer

Sanofi Strengthens Adult Vaccine Portfolio with $2.2B Dynavax Acquisition

CNS Pharmaceuticals Names Rami Levin as CEO in Leadership Transition

Johnson & Johnson Finalizes $3.05B Halda Therapeutics Acquisition to Expand Prostate Cancer Pipeline

bottom of page